Z
Zoltán Janka
Researcher at University of Szeged
Publications - 269
Citations - 6523
Zoltán Janka is an academic researcher from University of Szeged. The author has contributed to research in topics: Schizophrenia & Apolipoprotein E. The author has an hindex of 41, co-authored 264 publications receiving 6092 citations. Previous affiliations of Zoltán Janka include Albert Szent-Györgyi Medical University.
Papers
More filters
Journal ArticleDOI
The other face of depression, reduced positive affect : the role of catecholamines in causation and cure
David J. Nutt,Koen Demyttenaere,Zoltán Janka,Trond Aarre,Michel Bourin,Pier Luigi Canonico,José L. Carrasco,Steven Stahl +7 more
TL;DR: There is evidence to suggest that antidepressants that enhance noradrenergic and dopaminergic activity may afford a therapeutic advantage over serotonergic antidepressants in the treatment of symptoms associated with a reduction in positive affect.
Journal ArticleDOI
Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach.
TL;DR: Dysfunctions of sensory-perceptual analysis and working memory for spatial information distinguished the siblings of schizophrenia patients from the siblings with bipolar disorder, suggesting a common impairment of the fronto-hippocampal system.
Journal ArticleDOI
Sensitivity to reward and punishment and the prefrontal cortex in major depression.
TL;DR: Medicated patients with major depressive disorder show altered sensitivity to reward and punishment: immediate large reward enhanced related response patterns even when the strategy was disadvantageous and immediate large punishment did not prohibit relatedresponse patterns.
Journal ArticleDOI
Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease
János Kálmán,Anna Juhász,G. Laird,P. Dickens,Tamás Járdánházy,Ágnes Rimanóczy,I. Boncz,W. L. I. Parry-Jones,Zoltán Janka +8 more
TL;DR: Findings suggest a disease stage dependent general activation of the immune system both in sporadic AD and in DS with AD.
Journal ArticleDOI
Oxidative stress: a bridge between Down's syndrome and Alzheimer's disease.
TL;DR: A balanced up-regulation of endogenous antioxidants, together with multiple exogenous antioxidant supplementation, may be expected to be one of the most promising treatment methods for Down's syndrome and AD.